sulfur has been researched along with imatinib mesylate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, T; Ballinger, ML; de Haan, JB; Hashimura, K; Jandeleit-Dahm, K; Little, PJ; Osman, N; Rutledge, JC; Tannock, LR | 1 |
| Adam, T; Faber, E; Friedecký, D; Karlíková, R; Mičová, K; Najdekr, L; Vrobel, I | 1 |
| Martins, JBL; Nascimento, ÉCM; Rocha, KML | 1 |
| Abd Elhaleem, SM; Belal, F; Elsebaei, F; Shalan, S | 1 |
4 other study(ies) available for sulfur and imatinib mesylate
| Article | Year |
|---|---|
Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo.
Topics: Animals; Aorta; Apolipoproteins E; Benzamides; Dietary Fats; Disaccharides; Dose-Response Relationship, Drug; Glycosaminoglycans; Humans; Imatinib Mesylate; Lipid Metabolism; Lipoproteins, LDL; Mice; Molecular Weight; Muscle, Smooth, Vascular; Phosphorylation; Piperazines; Protein Binding; Proteoglycans; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Sulfur | 2010 |
Novel sulphur-containing imatinib metabolites found by untargeted LC-HRMS analysis.
Topics: Antineoplastic Agents; Chromatography, Liquid; Cysteine; Cystine; Humans; Imatinib Mesylate; Protein Kinase Inhibitors; Sulfur; Tandem Mass Spectrometry | 2017 |
Investigation on the interaction behavior of afatinib, dasatinib, and imatinib docked to the BCR-ABL protein.
Topics: Afatinib; Antineoplastic Agents; Catalytic Domain; Dasatinib; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methionine; Molecular Docking Simulation; Mutation; Quantum Theory; Sulfur | 2021 |
Turn-off fluorescence of nitrogen and sulfur carbon quantum dots as effective fluorescent probes for determination of imatinib. Application to biological fluids.
Topics: Carbon; Fluorescence; Fluorescent Dyes; Humans; Imatinib Mesylate; Nitrogen; Quantum Dots; Sulfur | 2022 |